The New York Times reported that Trump’s financial documents reveal the president’s three family trusts held investments in Regeneron as well as pharmaceutical giant Sanofi, which itself is a major shareholder in Regeneron.
Trump administration officials passed when Pfizer offered in late summer to sell the U.S. government additional doses of its COVID-19 vaccine, according to people familiar with the matter. Now Pfizer may not be able to provide more of its vaccine to the United States until next June because of its commitments to other countries, they said.
